Business Segments · Goodwill

Rhythmand Neuro — Goodwill

Boston Scientific Rhythmand Neuro — Goodwill decreased by 0.1% to $3.50B in Q4 2021 compared to the prior quarter.

Analysis

StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
Rolls up toGoodwill

How to read this metric

An increase suggests recent acquisitions in the neuro and cardiac rhythm space, while a decrease may indicate impairment or divestiture.

Detailed definition

Represents the carrying value of goodwill specifically allocated to the Rhythm and Neuro business segment. This asset ar...

Peer comparison

Common in medical device companies that grow through M&A; peers like Medtronic or Abbott report similar segment-level goodwill.

Metric ID: bsx_segment_rhythm_and_neuro_goodwill

Historical Data

3 periods
 Q2 '21Q3 '21Q4 '21
Value$3.12B$3.51B$3.50B
QoQ Change+12.4%-0.1%
Range$3.12B$3.51B

Frequently Asked Questions

What is Boston Scientific's rhythmand neuro — goodwill?
Boston Scientific (BSX) reported rhythmand neuro — goodwill of $3.50B in Q4 2021.
What does rhythmand neuro — goodwill mean?
The total value of intangible assets like brand reputation attributed to the Rhythm and Neuro business segment from past acquisitions.